Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Heart Lung Transplant. 2013 Aug 13;32(10):10.1016/j.healun.2013.07.004. doi: 10.1016/j.healun.2013.07.004

Table 1. Patient demographics.

Demographics Controls, n = 480 N (%) AMR, n = 21 N (%) p
Gender Female 208 (43%) 12 (57%) 0.26
Male 272 (57%) 9 (43%)
Age at time of transplant 51.4 ± 14.1 years 42.0 ± 16.2 years <0.01
Type of Transplant Bilateral 458 (95%) 20 (95%) 0.94
Single 19 (4%) 1 (5%)
Heart-Lung 3 (1%) 0 (0%)
Diagnosis COPD 135 (28%) 6 (29%) 0.21
A1AT Deficiency 28 (6%) 0 (0%)
Pulmonary fibrosis 161 (34%) 7 (33%)
CF 89 (19%) 5 (24%)
BOS / Retransplant 15 (3%) 2 (10%)
PAH 9 (2%) 0 (0%)
Other 43 (9%) 1 (5%)
CMV Status* D+ / R- 128 (27%) 9 (43%) 0.26
D+ or - / R+ 289 (60%) 10 (48%)
D- / R- 63 (13%) 2 (10%)
Allosensitized prior to transplant 136 (28%) 7 (33%) 0.63

A1AT: alpha-1-antitrypsin, BOS: bronchiolitis obliterans syndrome, CF: cystic fibrosis, COPD: chronic obstructive pulmonary disease, PAH: pulmonary arterial hypertension

*

D+ / R-: donor positive/recipient negative, D+ or- / R+: donor positive or negative, recipient negative, D- / R-: donor negative/recipient negative